Company Information

IND-SWIFT LTD.

NSE : INDSWFTLTDBSE : 524652ISIN CODE : INE788B01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE24.95-0.5 (-1.96 %)
PREV CLOSE ( ) 25.45
OPEN PRICE ( ) 24.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 24.95 (81677)
VOLUME 495
TODAY'S LOW / HIGH ( )24.95 24.95
52 WK LOW / HIGH ( )7.75 31.09
NSE24.85-0.5 (-1.97 %)
PREV CLOSE( ) 25.35
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 24.85 (38691)
VOLUME 1292
TODAY'S LOW / HIGH( ) 24.85 24.85
52 WK LOW / HIGH ( )7.65 31.2
ChairmanS R Mehta
Managing DirectorGopal Munjal
Company SecretaryGinny Uppal
Promoter & Non-Executive DirectorN R Munjal
Himanshu jain
Rishav Mehta
Joint Managing DirectorV R Mehta
Non Executive Independent DirectorSubhash Chander Galhotra
Anoop Michra
Jagvir Singh Ahluwalia
Bhupinder Singh
Incorporation Year : 06-06 1986

Registered Office :

Address : 781,Phase 2,Industrial Area Chandigarh,
Union Territory-160002 .

Phone : 0172-4680800 / 2638781

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.